Yingmeng Yao

417 total citations · 1 hit paper
6 papers, 137 citations indexed

About

Yingmeng Yao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yingmeng Yao has authored 6 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Yingmeng Yao's work include RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (1 paper) and Cell death mechanisms and regulation (1 paper). Yingmeng Yao is often cited by papers focused on RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (1 paper) and Cell death mechanisms and regulation (1 paper). Yingmeng Yao collaborates with scholars based in China, Taiwan and Hong Kong. Yingmeng Yao's co-authors include Jie Shi, Xiangling Xiao, Jinfang Zhang, Minling Gao, Bolin Xiang, Yishuang Sun, Chuan He, Bin Wang, Shanwen Ke and Wenjing Song and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular Cell and Nature Immunology.

In The Last Decade

Yingmeng Yao

4 papers receiving 137 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy

2024 62 citations Yishuang Sun, Yingmeng Yao et al. Proceedings of the National Academy of Sciences profile →

Peers

Yingmeng Yao

MB

ONCOL

PRM

IMMUN

CR

Jie Shi China

Ayushi S. Patel United States

Pierre Foidart Belgium

Andrew Mant Australia

Priya Chudasama Germany

Rachel A. Hongo United States

Amir Vajdi United States

Ethan M. Earlie United States

Bohan Dong China

Christine N. Evans United States

Jie Shi China

Yingmeng Yao

80 ×1.0

MB

60 ×1.0

ONCOL

56 ×1.0

PRM

38 ×1.0

IMMUN

33 ×1.0

CR

Citations per year, relative to Yingmeng Yao Yingmeng Yao (= 1×) peers Jie Shi

Countries citing papers authored by Yingmeng Yao

Since Specialization

Citations

This map shows the geographic impact of Yingmeng Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingmeng Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingmeng Yao more than expected).

Fields of papers citing papers by Yingmeng Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingmeng Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingmeng Yao. The network helps show where Yingmeng Yao may publish in the future.

Co-authorship network of co-authors of Yingmeng Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Yingmeng Yao. A scholar is included among the top collaborators of Yingmeng Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingmeng Yao. Yingmeng Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Yu, Haisheng, Jie Shi, Rong‐Rong He, et al.. (2025). Energy status orchestrates YTHDF1 phase separation and tumorigenesis. Cell Reports. 44(11). 116466–116466.

2.

Song, Wenjing, Chuan He, Yingmeng Yao, et al.. (2025). Targeting the UFL1-PARP1 axis amplifies anti-tumor immunity. Cell Reports. 44(10). 116433–116433.

3.

Xiang, Bolin, Meiling Zhang, Kai Li, et al.. (2025). The epitranscriptional factor PCIF1 orchestrates CD8+ T cell ferroptosis and activation to control antitumor immunity. Nature Immunology. 26(2). 252–264. 8 indexed citations

4.

He, Chuan, Hsin-Yi Chen, Minling Gao, et al.. (2024). UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity. Molecular Cell. 84(6). 1120–1138.e8. 35 indexed citations

5.

Gao, Minling, Jie Shi, Xiangling Xiao, et al.. (2024). PD-1 regulation in immune homeostasis and immunotherapy. Cancer Letters. 588. 216726–216726. 32 indexed citations

6.

Sun, Yishuang, Yingmeng Yao, Shanwen Ke, et al.. (2024). USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy. Proceedings of the National Academy of Sciences. 121(16). e2315541121–e2315541121. 62 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact